 | • レポートコード：20QY06-00759 • 出版社/出版日：QYResearch / 2020年6月3日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、131ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社の当調査資料では、アレクシファム薬のグローバル市場について種類別（テトラエチルチウラムジスルフィド、グルタチオン、EDTA、ペニシラミン、メチレンブルー、ジエチレントリアミン五酢酸、2-アミノエタンチオール、亜硝酸ナトリウム、ジメルカプトプロパノール、トリエチレンテトラミン）、用途別（内科、救急医療、病院、薬局）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・アレクシファム薬市場の概要 ・世界の主要地域別アレクシファム薬市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のアレクシファム薬市場規模2015-2026：種類別（テトラエチルチウラムジスルフィド、グルタチオン、EDTA、ペニシラミン、メチレンブルー、ジエチレントリアミン五酢酸、2-アミノエタンチオール、亜硝酸ナトリウム、ジメルカプトプロパノール、トリエチレンテトラミン） ・世界のアレクシファム薬市場規模2015-2026：用途別（内科、救急医療、病院、薬局） ・アレクシファム薬の北米市場規模2015-2020 ・アレクシファム薬のヨーロッパ市場規模2015-2020 ・アレクシファム薬の中国市場規模2015-2020 ・アレクシファム薬の日本市場規模2015-2020 ・アレクシファム薬の東南アジア市場規模2015-2020 ・アレクシファム薬のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Accord healthcare (Intas)、Actavis Elizabeth、Alpharma pharmaceuticals (Pfizer)、Amneal pharms、Apotex、Ethypharm、Fresenius kabi、TEVA、Gavis Phaemaceuticals、Hikma farmaceutica） ・アレクシファム薬の製造コスト分析 ・販売チャネル、流通業者、顧客 ・アレクシファム薬の市場動向・機会・課題 ・調査の結論 |
Alexipharmic drugs work as an antidote and are employed to ward off effects of previously administered medications and drug poisoning, it can also be used as a defense against various types if microbial infections.
Market Analysis and Insights: Global Alexipharmic Drugs Market
The global Alexipharmic Drugs market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026.
Global Alexipharmic Drugs Scope and Market Size
The global Alexipharmic Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Alexipharmic Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Alexipharmic Drugs market is segmented into
Tetraethylthiuram Disulfide
Glutathione
EDTA
Penicillamine
Methylene Blue
Diethylenetriaminepentaacetic Acid
2-Aminoethanethiol
Sodium Nitrite
Dimercapto Propanol
Triethylenetetramine
Segment by Application, the Alexipharmic Drugs market is segmented into
Internal Medicine
Medical Emergency
Hospital
Pharmacy
The Alexipharmic Drugs market is analysed and market size information is provided by regions (countries). Segment by Application, the Alexipharmic Drugs market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Alexipharmic Drugs Market Share Analysis
Alexipharmic Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Alexipharmic Drugs business, the date to enter into the Alexipharmic Drugs market, Alexipharmic Drugs product introduction, recent developments, etc.
The major vendors covered:
Accord healthcare (Intas)
Actavis Elizabeth
Alpharma pharmaceuticals (Pfizer)
Amneal pharms
Apotex
Ethypharm
Fresenius kabi
TEVA
Gavis Phaemaceuticals
Hikma farmaceutica
Table of Contents
1 Alexipharmic Drugs Market Overview
1.1 Alexipharmic Drugs Product Scope
1.2 Alexipharmic Drugs Segment by Type
1.2.1 Global Alexipharmic Drugs Sales by Type (2020-2026)
1.2.2 Tetraethylthiuram Disulfide
1.2.3 Glutathione
1.2.4 EDTA
1.2.5 Penicillamine
1.2.6 Methylene Blue
1.2.7 Diethylenetriaminepentaacetic Acid
1.2.8 2-Aminoethanethiol
1.2.9 Sodium Nitrite
1.2.10 Dimercapto Propanol
1.2.11 Triethylenetetramine
1.3 Alexipharmic Drugs Segment by Application
1.3.1 Global Alexipharmic Drugs Sales Comparison by Application (2020-2026)
1.3.2 Internal Medicine
1.3.3 Medical Emergency
1.3.4 Hospital
1.3.5 Pharmacy
1.4 Alexipharmic Drugs Market Estimates and Forecasts (2015-2026)
1.4.1 Global Alexipharmic Drugs Sales Growth Rate (2015-2026)
1.4.2 Global Alexipharmic Drugs Revenue and Growth Rate (2015-2026)
1.4.3 Global Alexipharmic Drugs Price Trends (2015-2026)
2 Alexipharmic Drugs Estimate and Forecast by Region
2.1 Global Alexipharmic Drugs Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Alexipharmic Drugs Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Alexipharmic Drugs Sales Market Share by Region (2015-2020)
2.2.2 Global Alexipharmic Drugs Revenue Market Share by Region (2015-2020)
2.3 Global Alexipharmic Drugs Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Alexipharmic Drugs Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Alexipharmic Drugs Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Alexipharmic Drugs Estimates and Projections (2015-2026)
2.4.2 Europe Alexipharmic Drugs Estimates and Projections (2015-2026)
2.4.3 China Alexipharmic Drugs Estimates and Projections (2015-2026)
2.4.4 Japan Alexipharmic Drugs Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Alexipharmic Drugs Estimates and Projections (2015-2026)
2.4.6 India Alexipharmic Drugs Estimates and Projections (2015-2026)
3 Global Alexipharmic Drugs Competition Landscape by Players
3.1 Global Top Alexipharmic Drugs Players by Sales (2015-2020)
3.2 Global Top Alexipharmic Drugs Players by Revenue (2015-2020)
3.3 Global Alexipharmic Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Alexipharmic Drugs as of 2019)
3.4 Global Alexipharmic Drugs Average Price by Company (2015-2020)
3.5 Manufacturers Alexipharmic Drugs Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Alexipharmic Drugs Players (Opinion Leaders)
4 Global Alexipharmic Drugs Market Size by Type
4.1 Global Alexipharmic Drugs Historic Market Review by Type (2015-2020)
4.1.1 Global Alexipharmic Drugs Sales Market Share by Type (2015-2020)
4.1.2 Global Alexipharmic Drugs Revenue Market Share by Type (2015-2020)
4.1.3 Global Alexipharmic Drugs Price by Type (2014-2020)
4.2 Global Alexipharmic Drugs Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Alexipharmic Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Alexipharmic Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Global Alexipharmic Drugs Price Forecast by Type (2021-2026)
5 Global Alexipharmic Drugs Market Size by Application
5.1 Global Alexipharmic Drugs Historic Market Review by Application (2015-2020)
5.1.1 Global Alexipharmic Drugs Sales Market Share by Application (2015-2020)
5.1.2 Global Alexipharmic Drugs Revenue Market Share by Application (2015-2020)
5.1.3 Global Alexipharmic Drugs Price by Application (2015-2020)
5.2 Global Alexipharmic Drugs Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Alexipharmic Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Alexipharmic Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Alexipharmic Drugs Price Forecast by Application (2021-2026)
3 North America Alexipharmic Drugs Market Facts & Figures
3.2 North America Alexipharmic Drugs Sales Market Share by Company (2015-2020)
3.3 North America Alexipharmic Drugs Sales Market Share by Type (2015-2020)
3.4 North America Alexipharmic Drugs Sales Market Share by Application (2015-2020)
4 Europe Alexipharmic Drugs Market Facts & Figures
4.2 Europe Alexipharmic Drugs Sales Market Share by Company (2015-2020)
4.3 Europe Alexipharmic Drugs Sales Market Share by Type (2015-2020)
4.4 Europe Alexipharmic Drugs Sales Market Share by Application (2015-2020)
5 China Alexipharmic Drugs Market Facts & Figures
5.2 China Alexipharmic Drugs Sales Market Share by Company (2015-2020)
5.3 China Alexipharmic Drugs Sales Market Share by Type (2015-2020)
5.4 China Alexipharmic Drugs Sales Market Share by Application (2015-2020)
6 Japan Alexipharmic Drugs Market Facts & Figures
6.2 Japan Alexipharmic Drugs Sales Market Share by Company (2015-2020)
6.3 Japan Alexipharmic Drugs Sales Market Share by Type (2015-2020)
6.4 Japan Alexipharmic Drugs Sales Market Share by Application (2015-2020)
7 Southeast Asia Alexipharmic Drugs Market Facts & Figures
7.2 Southeast Asia Alexipharmic Drugs Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Alexipharmic Drugs Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Alexipharmic Drugs Sales Market Share by Application (2015-2020)
8 India Alexipharmic Drugs Market Facts & Figures
8.2 India Alexipharmic Drugs Sales Market Share by Company (2015-2020)
8.3 India Alexipharmic Drugs Sales Market Share by Type (2015-2020)
8.4 India Alexipharmic Drugs Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Alexipharmic Drugs Business
12.1 Accord healthcare (Intas)
12.1.1 Accord healthcare (Intas) Alexipharmic Drugs Corporation Information
12.1.2 Accord healthcare (Intas) Alexipharmic Drugs Business Overview and Total Revenue
12.1.3 Accord healthcare (Intas) Alexipharmic Drugs Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Accord healthcare (Intas) Alexipharmic Drugs Products Offered
12.1.5 Accord healthcare (Intas) Recent Development
12.2 Actavis Elizabeth
12.2.1 Actavis Elizabeth Alexipharmic Drugs Corporation Information
12.2.2 Actavis Elizabeth Alexipharmic Drugs Business Overview and Total Revenue
12.2.3 Actavis Elizabeth Alexipharmic Drugs Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Actavis Elizabeth Alexipharmic Drugs Products Offered
12.2.5 Actavis Elizabeth Recent Development
12.3 Alpharma pharmaceuticals (Pfizer)
12.3.1 Alpharma pharmaceuticals (Pfizer) Alexipharmic Drugs Corporation Information
12.3.2 Alpharma pharmaceuticals (Pfizer) Alexipharmic Drugs Business Overview and Total Revenue
12.3.3 Alpharma pharmaceuticals (Pfizer) Alexipharmic Drugs Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Alpharma pharmaceuticals (Pfizer) Alexipharmic Drugs Products Offered
12.3.5 Alpharma pharmaceuticals (Pfizer) Recent Development
12.4 Amneal pharms
12.4.1 Amneal pharms Alexipharmic Drugs Corporation Information
12.4.2 Amneal pharms Alexipharmic Drugs Business Overview and Total Revenue
12.4.3 Amneal pharms Alexipharmic Drugs Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Amneal pharms Alexipharmic Drugs Products Offered
12.4.5 Amneal pharms Recent Development
12.5 Apotex
12.5.1 Apotex Alexipharmic Drugs Corporation Information
12.5.2 Apotex Alexipharmic Drugs Business Overview and Total Revenue
12.5.3 Apotex Alexipharmic Drugs Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Apotex Alexipharmic Drugs Products Offered
12.5.5 Apotex Recent Development
12.6 Ethypharm
12.6.1 Ethypharm Alexipharmic Drugs Corporation Information
12.6.2 Ethypharm Alexipharmic Drugs Business Overview and Total Revenue
12.6.3 Ethypharm Alexipharmic Drugs Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Ethypharm Alexipharmic Drugs Products Offered
12.6.5 Ethypharm Recent Development
12.7 Fresenius kabi
12.7.1 Fresenius kabi Alexipharmic Drugs Corporation Information
12.7.2 Fresenius kabi Alexipharmic Drugs Business Overview and Total Revenue
12.7.3 Fresenius kabi Alexipharmic Drugs Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Fresenius kabi Alexipharmic Drugs Products Offered
12.7.5 Fresenius kabi Recent Development
12.8 TEVA
12.8.1 TEVA Alexipharmic Drugs Corporation Information
12.8.2 TEVA Alexipharmic Drugs Business Overview and Total Revenue
12.8.3 TEVA Alexipharmic Drugs Sales, Revenue and Gross Margin (2015-2020)
12.8.4 TEVA Alexipharmic Drugs Products Offered
12.8.5 TEVA Recent Development
12.9 Gavis Phaemaceuticals
12.9.1 Gavis Phaemaceuticals Alexipharmic Drugs Corporation Information
12.9.2 Gavis Phaemaceuticals Alexipharmic Drugs Business Overview and Total Revenue
12.9.3 Gavis Phaemaceuticals Alexipharmic Drugs Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Gavis Phaemaceuticals Alexipharmic Drugs Products Offered
12.9.5 Gavis Phaemaceuticals Recent Development
12.10 Hikma farmaceutica
12.10.1 Hikma farmaceutica Alexipharmic Drugs Corporation Information
12.10.2 Hikma farmaceutica Alexipharmic Drugs Business Overview and Total Revenue
12.10.3 Hikma farmaceutica Alexipharmic Drugs Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Hikma farmaceutica Alexipharmic Drugs Products Offered
12.10.5 Hikma farmaceutica Recent Development
13 Alexipharmic Drugs Manufacturing Cost Analysis
13.1 Alexipharmic Drugs Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Alexipharmic Drugs
13.4 Alexipharmic Drugs Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Alexipharmic Drugs Distributors List
14.3 Alexipharmic Drugs Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Alexipharmic Drugs Sales (K Units) Growth Rate by Type (2020-2026)
Table 2. Global Alexipharmic Drugs Sales (K Units) Comparison by Application (2020-2026)
Table 3. Global Market Alexipharmic Drugs Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Alexipharmic Drugs Sales (K Units) by Region (2015-2020)
Table 5. Global Alexipharmic Drugs Sales Market Share by Region (2015-2020)
Table 6. Global Alexipharmic Drugs Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Alexipharmic Drugs Revenue Share by Region (2015-2020)
Table 8. Global Alexipharmic Drugs Sales (K Units) Forecast by Region (2021-2026)
Table 9. Global Alexipharmic Drugs Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Alexipharmic Drugs Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Alexipharmic Drugs Revenue Share Forecast by Region (2021-2026)
Table 12. Global Alexipharmic Drugs (K Units) of Key Companies (2015-2020)
Table 13. Global Alexipharmic Drugs Sales Share by Company (2015-2020)
Table 14. Global Alexipharmic Drugs Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Alexipharmic Drugs Revenue Share by Company (2015-2020)
Table 16. Global Alexipharmic Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Alexipharmic Drugs as of 2019)
Table 17. Global Alexipharmic Drugs Average Price (USD/Unit) of Key Company (2015-2020)
Table 18. Manufacturers Alexipharmic Drugs Manufacturing Sites and Area Served
Table 19. Manufacturers Alexipharmic Drugs Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Alexipharmic Drugs Players
Table 22. Global Alexipharmic Drugs Sales (K Units) by Type (2015-2020)
Table 23. Global Alexipharmic Drugs Sales Share by Type (2015-2020)
Table 24. Global Alexipharmic Drugs Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Alexipharmic Drugs Price (K Units) by Type (2015-2020)
Table 26. Global Alexipharmic Drugs Sales Share by Type (2021-2026)
Table 27. Global Alexipharmic Drugs Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Alexipharmic Drugs Revenue Share by Type (2021-2026)
Table 29. Global Alexipharmic Drugs Price (K Units) by Type (2021-2026)
Table 30. Global Alexipharmic Drugs Sales (K Units) by Application (2015-2020)
Table 31. Global Alexipharmic Drugs Sales Share by Application (2015-2020)
Table 32. Global Alexipharmic Drugs Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Alexipharmic Drugs Price (K Units) by Application (2015-2020)
Table 34. Global Alexipharmic Drugs Sales (K Units) by Application (2021-2026)
Table 35. Global Alexipharmic Drugs Sales Share by Application (2021-2026)
Table 36. Global Alexipharmic Drugs Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Alexipharmic Drugs Revenue Share by Application (2021-2026)
Table 38. Global Alexipharmic Drugs Price (K Units) by Application (2021-2026)
Table 39. United States Alexipharmic Drugs Sales (K Units) by Company (2015-2020)
Table 40. United States Alexipharmic Drugs Sales Market Share by Company (2015-2020)
Table 41. United States Alexipharmic Drugs Sales (K Units) by Type (2015-2020)
Table 42. United States Alexipharmic Drugs Sales Market Share by Type (2015-2020)
Table 43. United States Alexipharmic Drugs Sales (K Units) by Application (2015-2020)
Table 44. United States Alexipharmic Drugs Sales Market Share by Application (2015-2020)
Table 45. Europe Alexipharmic Drugs Sales (K Units) by Company (2015-2020)
Table 46. Europe Alexipharmic Drugs Sales Market Share by Company (2015-2020)
Table 47. Europe Alexipharmic Drugs Sales (K Units) by Type (2015-2020)
Table 48. Europe Alexipharmic Drugs Sales Market Share by Type (2015-2020)
Table 49. Europe Alexipharmic Drugs Sales (K Units) by Application (2015-2020)
Table 50. Europe Alexipharmic Drugs Sales Market Share by Type (2015-2020)
Table 51. China Alexipharmic Drugs Sales (K Units) by Company (2015-2020)
Table 52. China Alexipharmic Drugs Sales Market Share by Company (2015-2020)
Table 53. China Alexipharmic Drugs Sales (K Units) by Type (2015-2020)
Table 54. China Alexipharmic Drugs Sales Market Share by Type (2015-2020)
Table 55. China Alexipharmic Drugs Sales (K Units) by Application (2015-2020)
Table 56. China Alexipharmic Drugs Sales Market Share by Application (2015-2020)
Table 57. Japan Alexipharmic Drugs Sales (K Units) by Company (2015-2020)
Table 58. Japan Alexipharmic Drugs Sales Market Share by Company (2015-2020)
Table 59. Japan Alexipharmic Drugs Sales (K Units) by Type (2015-2020)
Table 60. Japan Alexipharmic Drugs Sales Market Share by Type (2015-2020)
Table 61. Japan Alexipharmic Drugs Sales (K Units) by Application (2015-2020)
Table 62. Japan Alexipharmic Drugs Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Alexipharmic Drugs Sales (K Units) by Company (2015-2020)
Table 64. Southeast Asia Alexipharmic Drugs Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Alexipharmic Drugs Sales (K Units) by Type (2015-2020)
Table 66. Southeast Asia Alexipharmic Drugs Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Alexipharmic Drugs Sales (K Units) by Type (2015-2020)
Table 68. Southeast Asia Alexipharmic Drugs Sales Market Share by Application (2015-2020)
Table 69. India Alexipharmic Drugs Sales (K Units) by Company (2015-2020)
Table 70. India Alexipharmic Drugs Sales Market Share by Company (2015-2020)
Table 71. India Alexipharmic Drugs Sales (K Units) by Type (2015-2020)
Table 72. India Alexipharmic Drugs Sales Market Share by Type (2015-2020)
Table 73. India Alexipharmic Drugs Sales (K Units) by Application (2015-2020)
Table 74. India Alexipharmic Drugs Sales Market Share by Application (2015-2020)
Table 75. Accord healthcare (Intas) Corporation Information
Table 76. Accord healthcare (Intas) Description and Business Overview
Table 77. Accord healthcare (Intas) Alexipharmic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 78. Accord healthcare (Intas) Alexipharmic Drugs Product
Table 79. Accord healthcare (Intas) Recent Development
Table 80. Actavis Elizabeth Corporation Information
Table 81. Actavis Elizabeth Description and Business Overview
Table 82. Actavis Elizabeth Alexipharmic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Actavis Elizabeth Alexipharmic Drugs Product
Table 84. Actavis Elizabeth Recent Development
Table 85. Alpharma pharmaceuticals (Pfizer) Corporation Information
Table 86. Alpharma pharmaceuticals (Pfizer) Description and Business Overview
Table 87. Alpharma pharmaceuticals (Pfizer) Alexipharmic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Alpharma pharmaceuticals (Pfizer) Alexipharmic Drugs Product
Table 89. Alpharma pharmaceuticals (Pfizer) Recent Development
Table 90. Amneal pharms Corporation Information
Table 91. Amneal pharms Description and Business Overview
Table 92. Amneal pharms Alexipharmic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Amneal pharms Alexipharmic Drugs Product
Table 94. Amneal pharms Recent Development
Table 95. Apotex Corporation Information
Table 96. Apotex Description and Business Overview
Table 97. Apotex Alexipharmic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Apotex Alexipharmic Drugs Product
Table 99. Apotex Recent Development
Table 100. Ethypharm Corporation Information
Table 101. Ethypharm Description and Business Overview
Table 102. Ethypharm Alexipharmic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Ethypharm Alexipharmic Drugs Product
Table 104. Ethypharm Recent Development
Table 105. Fresenius kabi Corporation Information
Table 106. Fresenius kabi Description and Business Overview
Table 107. Fresenius kabi Alexipharmic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Fresenius kabi Alexipharmic Drugs Product
Table 109. Fresenius kabi Recent Development
Table 110. TEVA Corporation Information
Table 111. TEVA Alexipharmic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 112. TEVA Description and Business Overview
Table 113. TEVA Alexipharmic Drugs Product
Table 114. TEVA Recent Development
Table 115. Gavis Phaemaceuticals Corporation Information
Table 116. Gavis Phaemaceuticals Alexipharmic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. Gavis Phaemaceuticals Description and Business Overview
Table 118. Gavis Phaemaceuticals Alexipharmic Drugs Product
Table 119. Gavis Phaemaceuticals Recent Development
Table 120. Hikma farmaceutica Corporation Information
Table 121. Hikma farmaceutica Description and Business Overview
Table 122. Hikma farmaceutica Alexipharmic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 123. Hikma farmaceutica Alexipharmic Drugs Product
Table 124. Hikma farmaceutica Recent Development
Table 125. Production Base and Market Concentration Rate of Raw Material
Table 126. Key Suppliers of Raw Materials
Table 127. Alexipharmic Drugs Distributors List
Table 128. Alexipharmic Drugs Customers List
Table 129. Market Key Trends
Table 130. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 131. Key Challenges
Table 132. Research Programs/Design for This Report
Table 133. Key Data Information from Secondary Sources
Table 134. Key Data Information from Primary Sources
List of Figures
Figure 1. Alexipharmic Drugs Product Picture
Figure 2. Global Alexipharmic Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Alexipharmic Drugs Market Share by Application in 2020 & 2026
Figure 6. Internal Medicine Examples
Figure 7. Medical Emergency Examples
Figure 8. Hospital Examples
Figure 9. Pharmacy Examples
Figure 10. Global Alexipharmic Drugs Sales (K Units) Growth Rate (2015-2026)
Figure 11. Global Alexipharmic Drugs Revenue (US$ Million) Growth Rate (2015-2026)
Figure 12. Global Alexipharmic Drugs Price Trends Growth Rate (2015-2026) (USD/Unit)
Figure 13. Global Alexipharmic Drugs Revenue Market Share by Region: 2015 VS 2020
Figure 14. Global Alexipharmic Drugs Revenue Market Share by Region: 2021 VS 2026
Figure 15. United States Alexipharmic Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. United States Alexipharmic Drugs Sales (K Units) Growth Rate (2015-2026)
Figure 17. Europe Alexipharmic Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. Europe Alexipharmic Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 19. China Alexipharmic Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. China Alexipharmic Drugs Sales (Million USD) and Growth Rate (2015-2026)
Figure 21. Japan Alexipharmic Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Japan Alexipharmic Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Alexipharmic Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. Southeast Asia Alexipharmic Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 25. India Alexipharmic Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 26. India Alexipharmic Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 27. Global 5 Largest Alexipharmic Drugs Players Market Share by Revenue in Alexipharmic Drugs 2015 & 2019
Figure 28. Alexipharmic Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 29. Global Alexipharmic Drugs Revenue Share by Type (2015-2020)
Figure 30. Global Alexipharmic Drugs Revenue Growth Rate by Type in 2015 & 2019
Figure 31. Global Alexipharmic Drugs Revenue Share by Application (2015-2020)
Figure 32. Global Alexipharmic Drugs Revenue Growth Rate by Application in 2015 & 2019
Figure 33. United States Alexipharmic Drugs Sales Market Share by Type in 2019
Figure 34. United States Alexipharmic Drugs Sales Market Share by Type in 2019
Figure 35. Europe Alexipharmic Drugs Sales Market Share by Company in 2019
Figure 36. Europe Alexipharmic Drugs Sales Market Share by Type in 2019
Figure 37. Europe Alexipharmic Drugs Sales Market Share by Application in 2019
Figure 38. China Alexipharmic Drugs Sales Market Share by Company in 2019
Figure 39. China Alexipharmic Drugs Sales Market Share by Type in 2019
Figure 40. China Alexipharmic Drugs Sales Market Share by Application in 2019
Figure 41. Japan Alexipharmic Drugs Sales Market Share by Company in 2019
Figure 42. Japan Alexipharmic Drugs Sales Market Share by Type in 2019
Figure 43. Japan Alexipharmic Drugs Sales Market Share by Application in 2019
Figure 44. Southeast Asia Alexipharmic Drugs Sales Market Share by Company in 2019
Figure 45. Southeast Asia Alexipharmic Drugs Sales Market Share by Type in 2019
Figure 46. Southeast Asia Alexipharmic Drugs Sales Market Share by Application in 2019
Figure 47. India Alexipharmic Drugs Sales Market Share by Company in 2019
Figure 48. India Alexipharmic Drugs Sales Market Share by Type in 2019
Figure 49. India Alexipharmic Drugs Sales Market Share by Application in 2019
Figure 50. Accord healthcare (Intas) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Actavis Elizabeth Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Alpharma pharmaceuticals (Pfizer) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Amneal pharms Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Apotex Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Ethypharm Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Fresenius kabi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. TEVA Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Gavis Phaemaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Hikma farmaceutica Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Key Raw Materials Price Trend
Figure 61. Manufacturing Cost Structure of Alexipharmic Drugs
Figure 62. Manufacturing Process Analysis of Alexipharmic Drugs
Figure 63. Alexipharmic Drugs Industrial Chain Analysis
Figure 64. Channels of Distribution
Figure 65. Distributors Profiles
Figure 66. Porter's Five Forces Analysis
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
エクセナチド薬の世界市場レポート2020 A recently published report by QY Research titled Global Exenatide Drugs Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate da…- リラグルチド薬の世界市場レポート2020 A recently published report by QY Research titled Global Liraglutide Drugs Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate …
- 内分泌系薬の世界市場レポート2020 Market Analysis and Insights: Global Endocrine System Drugs Market The global Endocrine System Drugs market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Endocrine System Drugs Scope and Market Size The global…
- コリン作動薬の世界市場レポート2020 Market Analysis and Insights: Global Cholinergic Drugs Market The global Cholinergic Drugs market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Cholinergic Drugs Scope and Market Size The global Cholinergic Dr…
- リンパ腫薬の世界市場レポート2020 Lymphoma is cancer that begins in infection-fighting cells of the immune system, called lymphocytes. These cells are in the lymph nodes, spleen, thymus, bone marrow, and other parts of the body. When you have lymphoma, lymphocytes change and grow out of control. The China average price of Lymphoma D…